Cantor Fitzgerald Forecasts RIGL FY2026 Earnings
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Rigel Pharmaceuticals in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska anticipates that the biotechnology company will post earnings per share of $1.05 for […]
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Rigel Pharmaceuticals in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska anticipates that the biotechnology company will post earnings per share of $1.05 for […]
